Michael Todd, ‘Where Science Meets Nature,’ Meets FDA Warning Letter
This article was originally published in The Rose Sheet
Executive Summary
Port St. Lucie, Fla.-based firm’s Intensive Eye Treatment and Knu Anti-Aging Face Lift Serum are unapproved drugs based on claims featured online, FDA says. The July 18 warning letter, posted to the agency’s website Aug. 16, was one of at least 10 that issued to skin-care companies in July.
You may also be interested in...
FDA’s July Warning Letters To Skin-Care Marketers Continue To Surface
Add Menscience Androceuticals, La Bella Figura and Healing Scents to the list of skin-care marketers hit with FDA warning letters in July. The agency’s policy is to wait for warning letter recipients to acknowledge receipt before posting the communications to its website.
FDA Warning Letter Barrage Continues With Five More To Close July
At least nine skin-care marketers received FDA warning letters in July for unapproved drug claims. In the month’s final two weeks, recipients included companies behind the Freeze 24-7 Instant Targeted Wrinkle Treatment and a Resurgent Stem Cell Firming Activator, among others.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.